Clinical Trials Directory

Explore 21,535 clinical trials worldwide

Showing 19151-19200 of 21,535 trials

Active filters:Status: Active, not recruiting

Clinical Trials (21,535)

NCT02623972
A Phase 2 Study of Eribulin Followed by AC as Preoperative Therapy for HER2-negative Inflammatory Breast Cancer
PHASE2Active, not recruiting
22 participants
Started: Feb 26, 2016 · Completed: Dec 31, 2026
2 conditions2 sponsors2 locations
NCT04439175
Testing GDC-0032 (Taselisib) as a Potential Targeted Treatment in Cancers With PIK3CA Genetic Changes (MATCH-Subprotocol I)
PHASE2Active, not recruiting
70 participants
Started: Feb 25, 2016 · Completed: Mar 19, 2026
6 conditions1 sponsor1 location
NCT04439357
Testing Trametinib as a Potential Targeted Treatment in Cancers With GNAQ or GNA11 Genetic Changes (MATCH-Subprotocol S2)
PHASE2Active, not recruiting
4 participants
Started: Feb 25, 2016 · Completed: Dec 31, 2025
6 conditions1 sponsor1 location
NCT04439318
Testing Trametinib as a Potential Targeted Treatment in Cancers With NF1 Genetic Changes (MATCH-Subprotocol S1)
PHASE2Active, not recruiting
50 participants
Started: Feb 25, 2016 · Completed: Dec 31, 2025
6 conditions1 sponsor1 location
NCT04439149
Testing GSK2636771 as a Potential Targeted Treatment in Cancers With PTEN Genetic Changes (MATCH-Subprotocol N)
PHASE2Active, not recruiting
24 participants
Started: Feb 25, 2016 · Completed: Nov 30, 2025
6 conditions1 sponsor1 location
NCT02713334
Cancer Patients Decision Making and Family Communication About Secondary Findings From Tumor Genomic Profiling
N/AActive, not recruiting
495 participants
Started: Feb 25, 2016 · Completed: Feb 25, 2026
1 condition1 sponsor1 location
NCT02710734
Risk Enabled Therapy After Initiating Neoadjuvant Chemotherapy for Bladder Cancer (RETAIN)
PHASE2Active, not recruiting
78 participants
Started: Feb 24, 2016 · Completed: Feb 28, 2034
1 condition1 sponsor4 locations
NCT06357988
Testing GDC-0449 (Vismodegib) as Potentially Targeted Treatment in Cancers With Smoothened or Patched 1 Mutant Tumors (MATCH - Subprotocol T)
PHASE2Active, not recruiting
35 participants
Started: Feb 24, 2016 · Completed: Dec 31, 2026
6 conditions1 sponsor1 location
NCT02478099
MPDL3280A-treatment-IST-UMCG
PHASE2Active, not recruiting
81 participants
Started: Feb 24, 2016 · Completed: Jul 31, 2024
1 condition1 sponsor1 location
NCT02453984
MPDL3280A-imaging-IST-UMCG
NAActive, not recruiting
45 participants
Started: Feb 24, 2016 · Completed: Jun 30, 2024
1 condition1 sponsor1 location
NCT02571725
PARP-inhibition and CTLA-4 Blockade in BRCA-deficient Ovarian Cancer
PHASE1/PHASE2Active, not recruiting
50 participants
Started: Feb 23, 2016 · Completed: Jul 15, 2027
3 conditions1 sponsor5 locations
NCT02734290
Standard of Care Chemotherapy Plus Pembrolizumab for Breast Cancer
PHASE1/PHASE2Active, not recruiting
29 participants
Started: Feb 23, 2016 · Completed: Dec 31, 2025
1 condition2 sponsors2 locations
NCT05049746
Identifying Decision Making Needs for Older Adult Women With Stage I-III Breast Cancer Considering Neoadjuvant or Adjuvant Chemotherapy
NAActive, not recruiting
95 participants
Started: Feb 23, 2016 · Completed: Feb 2, 2027
20 conditions1 sponsor1 location
NCT02671435
A Study of Durvalumab (MEDI4736) and Monalizumab in Solid Tumors
PHASE1/PHASE2Active, not recruiting
383 participants
Started: Feb 22, 2016 · Completed: Sep 1, 2025
1 condition1 sponsor49 locations
NCT02406729
Phase III Trial to Evaluate Efficacy and Safety of a Tetravalent Dengue Vaccine
PHASE3Active, not recruiting
16,935 participants
Started: Feb 22, 2016 · Completed: Nov 30, 2024
1 condition1 sponsor17 locations
NCT02689440
Dasatinib and Venetoclax in Treating Patients With Philadelphia Chromosome Positive or BCR-ABL1 Positive Early Chronic Phase Chronic Myelogenous Leukemia
PHASE2Active, not recruiting
155 participants
Started: Feb 19, 2016 · Completed: Dec 31, 2040
2 conditions2 sponsors1 location
NCT03430492
Sweden Cancerome Analysis Network - Breast (SCAN-B) Coupled to Psychological Resilience
N/AActive, not recruiting
985 participants
Started: Feb 15, 2016 · Completed: Dec 31, 2025
1 condition5 sponsors4 locations
NCT02626312
Radiation Therapy in Treating Patients With Hepatocellular Carcinoma, Cholangiocarcinoma, or Liver Metastasis Who Have Impaired Liver Function
PHASE1Active, not recruiting
36 participants
Started: Feb 15, 2016 · Completed: Apr 28, 2026
4 conditions2 sponsors1 location
NCT02453620
Entinostat, Nivolumab, and Ipilimumab in Treating Patients With Solid Tumors That Are Metastatic or Cannot Be Removed by Surgery or Locally Advanced or Metastatic HER2-Negative Breast Cancer
PHASE1Active, not recruiting
57 participants
Started: Feb 12, 2016 · Completed: Sep 17, 2026
5 conditions1 sponsor5 locations
NCT02625961
Study of Pembrolizumab (MK-3475) and Pembrolizumab With Other Investigational Agents in Participants With High Risk Non-muscle Invasive Bladder Cancer (MK-3475-057/KEYNOTE-057)
PHASE2Active, not recruiting
320 participants
Started: Feb 10, 2016 · Completed: Oct 31, 2025
1 condition1 sponsor0 locations
NCT02610673
WiCS-LV Post Market Surveillance Registry
N/AActive, not recruiting
100 participants
Started: Feb 8, 2016 · Completed: Jun 30, 2027
1 condition1 sponsor3 locations
NCT02649387
Ibrutinib in Treating Minimal Residual Disease in Patients With Chronic Lymphocytic Leukemia After Front-Line Therapy
PHASE2Active, not recruiting
35 participants
Started: Feb 8, 2016 · Completed: Jan 15, 2026
4 conditions1 sponsor1 location
NCT02659241
Adavosertib Before Surgery in Treating Patients With Advanced High Grade Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
EARLY_PHASE1Active, not recruiting
38 participants
Started: Feb 4, 2016 · Completed: Dec 31, 2026
22 conditions2 sponsors8 locations
NCT03905668
Fundamental Intelligent Building Blocks of the Intensive Care Unit (ICU) of the Future: Intelligent ICU of the Future
N/AActive, not recruiting
71 participants
Started: Feb 3, 2016 · Completed: Jul 31, 2028
2 conditions5 sponsors1 location
NCT02736656
Open-label Study to Evaluate Long-term Safety and Efficacy of SPN-812 (Viloxazine Extended-release Capsule)
PHASE3Active, not recruiting
1,400 participants
Started: Feb 2, 2016 · Completed: Sep 30, 2026
1 condition1 sponsor16 locations
NCT02381561
Ropidoxuridine in Treating Patients With Advanced Gastrointestinal Cancer Undergoing Radiation Therapy
PHASE1Active, not recruiting
19 participants
Started: Feb 1, 2016 · Completed: Mar 14, 2026
41 conditions1 sponsor1 location
NCT03444259
Prospective Project to Identify Biomarkers of Morbidity and Mortality in Cardiovascular Interventional Patients
N/AActive, not recruiting
1,001 participants
Started: Feb 1, 2016 · Completed: Dec 31, 2029
8 conditions2 sponsors1 location
NCT02662907
Cough, Expiratory Training, and Chronic Aspiration After Head and Neck Radiotherapy
NAActive, not recruiting
175 participants
Started: Feb 1, 2016 · Completed: Feb 2, 2027
1 condition2 sponsors1 location
NCT02625480
Study Evaluating Brexucabtagene Autoleucel (KTE-X19) in Pediatric and Adolescent Participants With Relapsed/Refractory B-precursor Acute Lymphoblastic Leukemia or Relapsed/Refractory B-Cell Non-Hodgkin Lymphoma
PHASE1/PHASE2Active, not recruiting
95 participants
Started: Feb 1, 2016 · Completed: Feb 28, 2026
2 conditions1 sponsor30 locations
NCT03256201
Exercise and Nutrition to Improve Pancreatic Cancer Outcomes
NAActive, not recruiting
95 participants
Started: Feb 1, 2016 · Completed: Mar 31, 2025
1 condition1 sponsor1 location
NCT04571177
PET Perfusion Imaging Techniques and Comparing Them to CT Perfusion Imaging in Stroke
N/AActive, not recruiting
20 participants
Started: Feb 1, 2016 · Completed: Dec 31, 2025
1 condition1 sponsor1 location
NCT03521921
GIse Registry Of Transcatheter Treatment of Mitral Valve regurgitaTiOn (GIOTTO)
N/AActive, not recruiting
1,500 participants
Started: Feb 1, 2016 · Completed: Sep 9, 2025
1 condition1 sponsor20 locations
NCT02849132
Effect of Entecavir Treatment on Regression and Disease Outcome in HBV-induced Liver Fibrosis and Cirrhosis Patients
PHASE4Active, not recruiting
800 participants
Started: Jan 31, 2016 · Completed: Dec 31, 2025
2 conditions8 sponsors20 locations
NCT02730338
INTense ExeRcise for SurviVAL Among Men with Metastatic Prostate Cancer (INTERVAL - GAP4)
NAActive, not recruiting
866 participants
Started: Jan 31, 2016 · Completed: Oct 31, 2026
1 condition5 sponsors18 locations
NCT02509286
Perioperative Chemotherapy Compared To Neoadjuvant Chemoradiation in Patients With Adenocarcinoma of the Esophagus
PHASE3Active, not recruiting
438 participants
Started: Jan 31, 2016 · Completed: Dec 31, 2024
2 conditions6 sponsors30 locations
NCT03033771
Dragon Study Europe
NAActive, not recruiting
27 participants
Started: Jan 31, 2016 · Completed: Dec 31, 2029
1 condition1 sponsor4 locations
NCT02751866
Early Intervention in Cognitive Aging
NAActive, not recruiting
250 participants
Started: Jan 31, 2016 · Completed: Jun 30, 2026
1 condition1 sponsor1 location
NCT02672761
Effect of 8 Weeks of MBSR Training on Neuroplasticity and Improvement of Attention, Memory and Well-Being
NAActive, not recruiting
140 participants
Started: Jan 31, 2016 · Completed: Jun 1, 2026
1 condition1 sponsor1 location
NCT04812730
Multimodal Bio-mechanical Analysis of Adult Spinal Deformity With Sagittal Plane Misalignment
NAActive, not recruiting
265 participants
Started: Jan 31, 2016 · Completed: Dec 31, 2028
1 condition1 sponsor1 location
NCT02431871
Sequelae of Developmental Dysplasia of the Hip
N/AActive, not recruiting
340 participants
Started: Jan 31, 2016 · Completed: Dec 31, 2026
2 conditions1 sponsor1 location
NCT02890095
Persistent Organic Pollutants and Breast Cancers (POPCASE)
NAActive, not recruiting
769 participants
Started: Jan 31, 2016 · Completed: Jun 30, 2034
1 condition1 sponsor3 locations
NCT02374112
Creatine Supplementation in Chronic Fatigue Syndrome
NAActive, not recruiting
60 participants
Started: Jan 31, 2016 · Completed: Dec 31, 2025
1 condition1 sponsor0 locations
NCT02664870
Evaluation of Biomarkers in Human Synovial Fluid
N/AActive, not recruiting
149 participants
Started: Jan 31, 2016 · Completed: Jan 1, 2028
1 condition1 sponsor1 location
NCT02973529
The Bioresorbable Implants for Scaffolding Obstructions in Randomized Bifurcations (BIFSORB) Study
NAActive, not recruiting
120 participants
Started: Jan 31, 2016 · Completed: Sep 30, 2028
1 condition1 sponsor4 locations
NCT02802033
A Multicenter Prospective Registry for the Management of Degenerative Spine Disorders
N/AActive, not recruiting
908 participants
Started: Jan 31, 2016 · Completed: Dec 31, 2026
1 condition2 sponsors7 locations
NCT02841618
The Healthy Cookie Study: Understanding How Healthy Cookies Affect Fat in the Blood,
NAActive, not recruiting
123 participants
Started: Jan 31, 2016 · Completed: Dec 1, 2026
1 condition1 sponsor1 location
NCT02641093
Phase II Trial of Adjuvant Cisplatin and Radiation With Pembrolizumab in Resected Head and Neck Squamous Cell Carcinoma
PHASE2Active, not recruiting
96 participants
Started: Jan 31, 2016 · Completed: Nov 2, 2025
1 condition2 sponsors6 locations
NCT02845882
LBL-2016 for Children or Adolescents in China
PHASE3Active, not recruiting
150 participants
Started: Jan 31, 2016 · Completed: Dec 31, 2031
1 condition9 sponsors2 locations
NCT02901821
Predicting Concussion Outcomes With Salivary miRNA
N/AActive, not recruiting
700 participants
Started: Jan 31, 2016 · Completed: Jun 30, 2026
1 condition1 sponsor1 location
NCT02657486
BGJ398 in Non-Muscle-Invasive Urothelial Carcinoma of the Bladder
NAActive, not recruiting
4 participants
Started: Jan 31, 2016 · Completed: Jan 31, 2026
2 conditions1 sponsor1 location